Jean-Paul Pirnay
Jean-Paul Pirnay
Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, Brussels, Belgium
Verified email at
Cited by
Cited by
Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 …
P Jault, T Leclerc, S Jennes, JP Pirnay, YA Que, G Resch, AF Rousseau, ...
The Lancet Infectious Diseases 19 (1), 35-45, 2019
Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials
M Merabishvili, JP Pirnay, G Verbeken, N Chanishvili, M Tediashvili, ...
PloS one 4 (3), e4944, 2009
Direct detection and identification of Pseudomonas aeruginosa in clinical samples such as skin biopsy specimens and expectorations by multiplex PCR based on two outer membrane …
D De Vos, A Lim Jr, JP Pirnay, M Struelens, C Vandenvelde, ...
Journal of clinical microbiology 35 (6), 1295-1299, 1997
Engineered endolysin-based “Artilysins” to combat multidrug-resistant gram-negative pathogens
Y Briers, M Walmagh, V Van Puyenbroeck, A Cornelissen, W Cenens, ...
MBio 5 (4), 10.1128/mbio. 01379-14, 2014
The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?
JP Pirnay, D De Vos, G Verbeken, M Merabishvili, N Chanishvili, ...
Pharmaceutical research 28, 934-937, 2011
Pseudomonas aeruginosa Population Structure Revisited
JP Pirnay, F Bilocq, B Pot, P Cornelis, M Zizi, J Van Eldere, P Deschaght, ...
PloS one 4 (11), e7740, 2009
The magistral phage
JP Pirnay, G Verbeken, PJ Ceyssens, I Huys, D De Vos, C Ameloot, ...
Viruses 10 (2), 64, 2018
Experimental phage therapy of burn wound infection: difficult first steps
T Rose, G Verbeken, D De Vos, M Merabishvili, M Vaneechoutte, ...
International journal of burns and trauma 4 (2), 66, 2014
Molecular Epidemiology of Pseudomonas aeruginosa Colonization in a Burn Unit: Persistence of a Multidrug-Resistant Clone and a Silver Sulfadiazine-Resistant …
JP Pirnay, D De Vos, C Cochez, F Bilocq, J Pirson, M Struelens, ...
Journal of clinical microbiology 41 (3), 1192-1202, 2003
Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury—a case report
S Jennes, M Merabishvili, P Soentjens, KW Pang, T Rose, E Keersebilck, ...
Critical Care 21, 1-3, 2017
Quality and safety requirements for sustainable phage therapy products
JP Pirnay, BG Blasdel, L Bretaudeau, A Buckling, N Chanishvili, JR Clark, ...
Pharmaceutical research 32, 2173-2179, 2015
FpvB, an alternative type I ferripyoverdine receptor of Pseudomonas aeruginosa
B Ghysels, BTM Dieu, SA Beatson, JP Pirnay, UA Ochsner, ML Vasil, ...
Microbiology 150 (6), 1671-1680, 2004
Art-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosa
Y Briers, M Walmagh, B Grymonprez, M Biebl, JP Pirnay, V Defraine, ...
Antimicrobial agents and chemotherapy 58 (7), 3774-3784, 2014
Global Pseudomonas aeruginosa biodiversity as reflected in a Belgian river
JP Pirnay, S Matthijs, H Colak, P Chablain, F Bilocq, J Van Eldere, ...
Environmental microbiology 7 (7), 969-980, 2005
Effects of Sequential and Simultaneous Applications of Bacteriophages on Populations of Pseudomonas aeruginosa In Vitro and in Wax Moth Larvae
AR Hall, D De Vos, VP Friman, JP Pirnay, A Buckling
Applied and environmental microbiology 78 (16), 5646-5652, 2012
Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental isolates
JP Pirnay, DD Vos, D Mossialos, A Vanderkelen, P Cornelis, M Zizi
Environmental microbiology 4 (12), 872-882, 2002
Identification of new, conserved, non‐ribosomal peptide synthetases from fluorescent pseudomonads involved in the biosynthesis of the siderophore pyoverdine
D Mossialos, U Ochsner, C Baysse, P Chablain, JP Pirnay, N Koedam, ...
Molecular microbiology 45 (6), 1673-1685, 2002
Clinical utilization of genomics data produced by the international Pseudomonas aeruginosa consortium
L Freschi, J Jeukens, I Kukavica-Ibrulj, B Boyle, MJ Dupont, J Laroche, ...
Frontiers in microbiology 6, 1036, 2015
Pseudomonas aeruginosa displays an epidemic population structure
JP Pirnay, D De Vos, C Cochez, F Bilocq, A Vanderkelen, M Zizi, ...
Environmental Microbiology 4 (12), 898-911, 2002
Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review
S Uyttebroek, B Chen, J Onsea, F Ruythooren, Y Debaveye, D Devolder, ...
The Lancet Infectious Diseases, 2022
The system can't perform the operation now. Try again later.
Articles 1–20